The company said operating revenue for Q3 was $44.7 billion, up $2.2 billion from a year earlier. It said adjusted operating gain was $2.4 billion and adjusted operating margin was 5.3%.

1. 01

   The company said operating revenue for Q3 was $44.7 billion, up $2.2 billion from a year earlier. It said adjusted operating gain was $2.4 billion and adjusted operating margin was 5.3%.

2. 02

   Elevance Health said its benefit expense ratio for Q3 was 89.5%, up 270 basis points. The company cited the timing mismatch between Medicaid rates and higher member acuity as the main factor.

3. 03

   The company said operating cash flow for Q3 was $2.7 billion. It repurchased 0.1 million shares of common stock for $60 million in Q3 and paid $378 million in dividends at a quarterly rate of $1.63 per share.

4. 04

   Elevance Health said that, given its results for Q3 and the timing mismatch between Medicaid rates and acuity, it now expects GAAP net income per diluted share of approximately $26.50 for 2024 and adjusted net income per diluted share of approximately $33.00.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.